The global compressor oil market is experiencing robust expansion, driven by surging demand from manufacturing, automotive, ...

Our blueprint unfolds in four overlapping phases—each grounded in neuroscience, real-world examples, and scalable digital ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a potent and ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended September 30, 2025, ...

The modern era of biobased innovation was catalyzed by policy action. In 1999, President Bill Clinton issued Executive Order ...

Current demand for plastics and chemical raw materials is met through large-scale production of ethylene from fossil fuels.

Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

According to Towards Chemical and Materials, the global Lactic Acid market size is calculated at USD 4.62 billion in 2025 and ...

Plant a seed and, if the conditions are right, the seed grows. The process seems simple enough at first glance and is something many of us may feel like we learned in elementary school.

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Unique Au-Rich Porphyry Discovery is Closely Integrated with Epithermal Au-Ag-Mo-Cu System at Maestro Project, British ...